Global Ultrasound Enhancing Agents Market Trends and Forecast to 2031

According To The Insight Partners, Global Ultrasound-Enhancing Agents Market forecast is derived on the basis of findings from various secondary and primary research sources. According to The Insight Partners' estimates, the market was valued at US$ 756.61 million in 2023 and is expected to reach US$ 2,511.52 million by 2031; it is estimated to record a CAGR of 16.2% during 2023–2031.

The global ultrasound-enhancing agents market is undergoing transformative growth, driven by technological innovation, expanding clinical applications, and rising demand for non-invasive diagnostic tools. These agents, primarily composed of gas-filled microbubbles, significantly enhance the clarity of ultrasound imaging by improving the visualization of blood flow and tissue perfusion.

Figure out what’s there in this deal| Get a glimpse through a sample at - https://www.theinsightpartners.com/sample/TIPRE00039130

Their safety profile—lacking nephrotoxicity and ionizing radiation—makes them ideal for repeated use across diverse patient populations, including those with renal impairment and pediatric patients. Recent advancements have focused on developing second-generation agents with improved stability and targeted imaging capabilities, enabling earlier and more accurate disease detection, particularly in oncology and cardiovascular care.

Market Trends and Innovations

A key trend reshaping the market is the development of targeted contrast agents using nanomedicine. These next-generation agents, ranging from 100–500 nm in size, are engineered to bind to specific molecular markers on tumor cells, allowing for highly sensitive and specific imaging of solid tumors. This precision enhances diagnostic accuracy and supports personalized treatment monitoring. Additionally, ultrafast imaging and advanced signal processing techniques are expanding the utility of ultrasound into therapeutic applications, such as targeted drug delivery and focused ultrasound surgery. The integration of artificial intelligence in image analysis is further improving diagnostic consistency and efficiency, reducing operator dependency and enhancing clinical outcomes.

Regional and Segmental Outlook

North America currently holds the largest market share, driven by the presence of major players like Lantheus Holdings Inc. and GE Healthcare, favorable reimbursement policies, and a high volume of ultrasound procedures. The U.S. leads the region, with increasing FDA approvals broadening clinical applications. Meanwhile, the Asia Pacific region is projected to witness the fastest growth, fueled by rising healthcare expenditures, expanding clinical research, and growing awareness of advanced imaging technologies. By application, abdominal imaging dominates the market, particularly in liver lesion characterization, while cardiovascular imaging is expected to grow at the highest compound annual growth rate (CAGR) due to increased use in echocardiography. Hospitals remain the primary end users, though diagnostic and imaging centers are anticipated to see the fastest adoption.

Recent Market Developments

Recent regulatory milestones underscore the market’s momentum. In May 2025, the FDA approved GE HealthCare’s Optison for pediatric use, expanding its indication to improve echocardiogram clarity in children with suboptimal imaging. This follows a phase IV study demonstrating that Optison enhances endocardial border delineation and reduces suboptimal image interpretation in pediatric patients. Similarly, Lantheus received FDA approval for Definity’s use in pediatric echocardiography in 2024, reflecting a broader trend toward safer, non-invasive imaging for younger populations. These approvals are expected to drive adoption in pediatric cardiology and support long-term market expansion.

Market Forecast and Strategic Insights

• Market Size in 2023: US$ 756.61 million
• Projected Market Size by 2031: US$ 2,511.52 million
• Global CAGR (2023–2031): 16.2%
• Dominant Product Type: Second-generation agents (larger market share and higher growth)
• Leading Application: Abdominal imaging (largest share), Cardiovascular imaging (highest CAGR)
• Primary End User: Hospitals (largest share), Diagnostic and imaging centers (highest CAGR)
• Regional Leader: North America (largest share), Asia Pacific (fastest growth)

Major companies such as GE Healthcare, Lantheus Holdings Inc., Bracco Diagnostics Inc., and FUJIFILM VisualSonics, Inc. are driving innovation through product launches, strategic partnerships, and research collaborations. For instance, Samsung Medison and Bracco Imaging signed an MoU in 2024 to co-develop high-frequency and super-resolution imaging protocols, signaling a shift toward integrated diagnostic ecosystems.

Get Premium Research Report Market Size and Growth Report by 2031 at: https://www.theinsightpartners.com/buy/TIPRE00039130

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us: If you have any queries about this report or if you would like further information, please contact us:

• Contact Person: Ankit Mathur
• E-mail: sales@theinsightpartners.com
• Phone: +1-646-491-9876

Also Available in :  Korean | German | Japanese | French | Arabic | Chinese | Italian | Spanish